Press Releases
ERBELLA AQ Showcases Liquid-Type PLLA and Cross-Linked HA So…
[Istanbul, Türkiye – September 2025] The premium medical aesthetics brand ERBELLA, developed by USCarePharm...
등록일 2025.10.13
ERBELLA Successfully Concludes Participation at KAAD 2025 Su…
ERBELLA, the premium medical aesthetics brand by USCarePharm, announced its successful participation in the 15...
등록일 2025.08.22
USCarePharm Presents Novel Vascular Health Ingredient at the…
USCarePharm Co., Ltd., a leader in natural material-based R&D, announced its recent presentation of new resear...
등록일 2025.07.28
USCarePharm to Present Anti-Aging Vascular Ingredient Resear…
USCarePharm Co., Ltd., a leading innovator in bio-based functional ingredients, will unveil its latest researc...
USCarePharm Ramps Up R&D for Pharmaceutical Actives and Nutr…
USCarePharm Expands R&D for Functional Pharmaceutical and Nutraceutical Ingredients Derived from Natural and B...
등록일 2025.03.28
USCarePharm Files PCT International Patent for Lipid Metabol…
[DataNet] USCarePharm, a leading company specialized in the research and development of functional natural in...
USCarePharm Files PCT International Patent for ‘Composition …
USCarePharm Files PCT International Patent for Composition Improving Lipid Metabolism Disorders [Korea Financ...
[Gyeonggi-do's Future with Promising SMEs] USCarePharm Co., …
USCarePharm CEO Song Seok-jin: “Bringing Innovation to Skin Health with Advanced Anti-Aging Technologies” "Ou...
개인정보 수집 및 이용동의
-
